Vaccine Production: Agreement Signed For Production Of Covid-19 Vaccine

Myanmar scheduled to produce COVID-19 vaccine at the end of January by purchasing of Ready to fill Bulk from China. Myanmar and China signed RTF Bulk Purchase Agreement for production of COVID-19 vaccine on Wednesday.

The signing ceremony took place in Yangon with the attendance of Chairman of the Supervisory Committee for COVID-19 Vaccine Production, Union Minister for Industry U Charlie Than, Union Minister for Health Dr Thet Khaing Win and the officials from Sinopharm China National Biotec Group.

At the ceremony, the Union Minister for Industry Dr Charlie Than said COVID-19 is a highly contagious disease that is now spreading around the world, and vaccination is the most effective way to prevent the spread of COVID-19. Efforts are also being made to develop the COVID-19 vaccine in various parts of the world. By 2021, Myanmar had purchased 26 million doses of the Sinopharm vaccine. According to the Ministry of Health, the Sinopharm COVID-19 vaccine has been shown to have fewer side effects and is more effective. Efforts were made to purchase the COVID-19 vaccine from Sinopharm CNBG as Ready to Fill Bulk. According to the MoU, Myanmar will produce 10 million doses of (RTF Bulk) Sinopharm vaccines from China.

Chairman Mr Jingzhen Liu of Sinopharm Group said Sinopharm CNBG is a leading manufacturer and exporter of pharmaceuticals in China. It is engaged in medical treatment and industry and is the second-largest pharmaceutical manufacturer in Asia. The World Health Organization (WHO) has approved the emergency use of Sinopharm COVID-19 vaccines produced by the company. He also said that he will continue to cooperate in the prevention and control of the pandemic in Myanmar through the virtual system. Next, an agreement to purchase 10 million RTF Bulk Doses of Sinopharm COVID-19 vaccine was signed by Managing Director of Myanmar Pharmaceutical Enterprise U Myo Zar Ni Win and Mr Yang on behalf of Sinopharm China National Biotech Group.